Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000248714 | SCV000314788 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000721775 | SCV000721823 | likely benign | not provided | 2021-05-10 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000721775 | SCV000885149 | likely benign | not provided | 2017-12-05 | criteria provided, single submitter | clinical testing | Although the c.246C>T variant (rs148244188) has not been reported in the medical literature, it is listed in the Genome Aggregation Database (gnomAD) browser with an allele frequency of 0.3% in the non-Finnish European population (identified in 389 out of 126,714 chromosomes; 1 homozygote) and is classified as likely benign in ClinVar (Variant ID: 261968). The cytosine at nucleotide 246 is not conserved, and computational analyses predict that this variant does not affect splicing of the CCM2 mRNA (Alamut software v2.10.0). Therefore, based on the available information, the c.246C>T variant is classified as likely benign. |
Labcorp Genetics |
RCV001087605 | SCV001013205 | benign | Cerebral cavernous malformation 2 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002450783 | SCV002736214 | likely benign | Inborn genetic diseases | 2022-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000721775 | SCV004156861 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | CCM2: BP4, BP7, BS1 |
Breakthrough Genomics, |
RCV000721775 | SCV005227319 | likely benign | not provided | criteria provided, single submitter | not provided |